LARP7
protein-codingLa ribonucleoprotein 7, transcriptional regulator, the group of RNA binding motif containing|7SK snRNP complex|La ribonucleoproteins
Gene summary
This gene encodes a protein which is found in the 7SK snRNP (small nuclear ribonucleoprotein). This snRNP complex inhibits a cyclin-dependent kinase, positive transcription elongation factor b, which is required for paused RNA polymerase II at a promoter to begin transcription elongation. A pseudogene of this gene is located on chromosome 3. Alternative splicing results in multiple transcript variants. [provided by RefSeq, May 2012]
MANE transcript
Inheritance
ClinVar variants
Top phenotype
gnomAD constraint
Max pathogenic AF
Genomic locus
External References & Databases
Transcript & Mutation Effects
hg38 • Region Span ~20.6 kbGenCC Phenotypes & Disease Associations
Curated gene-disease validity assertions and inheritance patterns
Inheritance Pattern: AR
Disease ID:MONDO:0014031
Submitter: Ambry Genetics
Inheritance Pattern: AR
Disease ID:MONDO:0014031
Submitter: G2P
Inheritance Pattern: AR
Disease ID:MONDO:0014031
Submitter: PanelApp Australia
Inheritance Pattern: AR
Disease ID:MONDO:0014031
Submitter: Labcorp Genetics (formerly Invitae)
Clinical Genomic Database (CGD)
Manifestation: Craniofacial; Musculoskeletal; Neurologic
Intervention: General
Rationale: Genetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testing
ClinVar Associated Diseases & Phenotypes
Reported disease conditions connected to LARP7 variants in ClinVar
ClinVar Variants & Pathogenicity by Type
Statistics based on transcript NM_016648.4. Only rare variants are included.
We include only reliable ClinVar variants with their consequences to MANE Select, MANE Plus Clinical transcripts, or transcripts with TSL equal to 1. Click a count to filter the variants table below.
Slight differences between displayed counts and ClinVar may occur due to a different transcript/consequence chosen by our variant effect predictor, or because we classify Benign/Likely benign as Likely benign and Pathogenic/Likely pathogenic as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 2 | 57 | 59 | |||
| missense | 2 | 127 | 8 | 1 | 138 | |
| nonsense | 6 | 7 | 13 | |||
| start loss | 0 | |||||
| frameshift | 45 | 29 | 2 | 76 | ||
| splice donor/acceptor (+/-2bp) | 3 | 11 | 4 | 18 | ||
| Total | 54 | 49 | 135 | 65 | 1 | 304 |
Highest pathogenic variant AF is 0.00005637918
Transcript Catalog
Annotated transcript isoforms across RefSeq and Ensembl databases
| Transcript ID | Source | Protein ID | Coding Exons | MANE Status |
|---|---|---|---|---|
| RefSeq | NP_057732.2 | 12 | MANE Select | |
| Ensembl | ENSP00000344950.5 | 12 | MANE Select | |
| RefSeq | NP_001253968.2 | 12 | Standard | |
| RefSeq | NP_001357903.1 | 12 | Standard |
Model Organisms & Knockout Phenotypes
Observed phenotypic effects in mouse and zebrafish models
| Gene / Model | Organism | Observed Phenotype |
|---|---|---|
| larp7 | Danio rerio | Structure: atrium Quality: dilated abnormal |
Gene Ontology (GO) Annotations & Pathways
Biological processes, molecular functions, cellular components and pathways
Biological Process
- RNA processing
Molecular Function
- RNA binding
- protein binding
Cellular Component
- nucleoplasm
- cytosol
- ribonucleoprotein complex
gnomAD Constraint
Source:
- Gene type
- protein_coding
- Transcript type
- protein_coding
- Transcript
- ENST00000509061
- Coding exons
- 13
- Length
- 20629
- Individuals with no LoFs
- 125628
- Homozygous LoFs
- 0
- Heterozygous LoFs
- 120
- Defined
- 125748
- p
- 0.000477
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible | |
|---|---|---|---|---|---|---|
| Missense | -0.268 | 297 | 284 | 1.04 | 0.0000134 | 3890 |
| Missense (PolyPhen) | 74 | 97.722 | 0.75725 | 1392 | ||
| Synonymous | -2.06 | 118 | 92.7 | 1.27 | 0.00000438 | 1025 |
| Loss of Function | 2.22 | 16 | 28.9 | 0.554 | 0.00000141 | 422 |
Population LoF Frequency
| Population | CAF | p-value | Status |
|---|---|---|---|
| African | 0.00052 | 0.00049 | rare |
| Latino/Admixed American | 0.00026 | 0.00023 | rare |
| Ashkenazi Jewish | 0.00033 | 0.00030 | rare |
| East Asian | 0.00058 | 0.00054 | rare |
| Finnish | 0.000047 | 0.000046 | rare |
| European (Non-Finnish) | 0.00062 | 0.00058 | rare |
| South Asian | 0.00071 | 0.00065 | rare |
| Other | 0.00073 | 0.00065 | rare |
dbNSFP Gene Annotations
Source:
- Function
- FUNCTION: Negative transcriptional regulator of polymerase II genes, acting by means of the 7SK RNP system. Within the 7SK RNP complex, the positive transcription elongation factor b (P-TEFb) is sequestered in an inactive form, preventing RNA polymerase II phosphorylation and subsequent transcriptional elongation. {ECO:0000269|PubMed:18249148, ECO:0000269|PubMed:18483487}.;
- Disease
- DISEASE: Alazami syndrome (ALAZS) [MIM:615071]: A syndromic form of primordial dwarfism, a condition characterized by severe growth restriction that has its onset in utero, and results in short stature and undersize. ALAZS patients manifest severe intellectual disability and distinct facial features including malar hypoplasia, deep-set eyes, broad nose, short philtrum, and macrostomia. Some patients have non-specific and inconsistent skeletal findings, for example, scoliosis and mild epiphyseal changes in the proximal phalanges, but no frank dysplasia. {ECO:0000269|PubMed:21937992, ECO:0000269|PubMed:22865833}. Note=The disease is caused by mutations affecting the gene represented in this entry.;
Recessive Scores
- pRec
- 0.113
Intolerance Scores
- LoFtool
- 0.969
- RVIS EVS
- 0.24
- RVIS percentile EVS
- 69.46
Essentials
- Essential (CRISPR)
- N
- Essential (CRISPR2)
- S
- Essential (gene trap)
- N
- Indispensability pred.
- E
- Indispensability score
- 0.987
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Medium | Medium |
| Primary Immunodeficiency | Medium | Medium | Medium |
| Cancer | Medium | Medium | Medium |